Home Department: Bioengineering
Supported by: Anonymous Donor
Mentor: Sharon Pitteri, Radiology
Alisha is investigating small molecule drugs that are potent against breast cancer cell lines using quantitative proteomics technology. She will compare treated and untreated cells to identify which proteins have altered levels in the treated cells. The experiment is being conducted to gain a deeper understanding of what proteins and pathways these drugs are targeting, in order to design more potent analogs that will ultimately be more successful in killing breast cancer cells.
Alisha Birk1, Catherine Going1, Vineet Kumar2, Sanjay Malhotra2, Sharon Pitteri1
[Departments of Radiology1 and Radiation Oncology2, Stanford University]